This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

USTR announces investigation into several countries for 'structural excess capacity'

( March 11, 2026, 23:37 GMT | Official Statement) -- MLex Summary: The office of the US Trade Representative launched a Section 301 trade investigation into alleged unfair trade practices involving "structural excess capacity and production in manufacturing sectors." USTR said excess capacity issues in foreign countries has burdened US commerce and supply chains. The office cited a number of sectors involved, including steel and aluminum, glass, paper, plastics, processed food and beverages, robotics, transportation equipment and semiconductors. USTR also cited a number of countries that the US has concerns with on the issue, including China, Singapore, Switzerland, Norway, Indonesia, Malaysia, Cambodia, Thailand, Korea, Vietnam, Taiwan, Bangladesh, Mexico, Japan and India, along with the European Union. USTR will hold public hearings on each jurisdiction named starting May 5.Full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections